Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CDNF Protein

CDNF Origin: Human Host: CHO Cells Recombinant WB, SDS, CC, in vivo Active
Catalog No. ABIN1405918
  • Target See all CDNF Proteins
    CDNF (Cerebral Dopamine Neurotrophic Factor (CDNF))
    Protein Type
    Recombinant
    Biological Activity
    Active
    Origin
    • 8
    • 5
    • 3
    Human
    Source
    • 8
    • 3
    • 2
    • 1
    • 1
    • 1
    CHO Cells
    Application
    Western Blotting (WB), SDS-PAGE (SDS), Cell Culture (CC), In vivo Studies (in vivo)
    Characteristics
    Biological properties: Protein is biologically active. Suitable for cell culture and in vivo testing. Biological activity of human CDNF was tested in rat 6-OHDA model of Parkinson’s disease and shown to be both neuroprotective and neurorestorative (for methods see: Lindholm et al. 2007, Voutilainen et al. 2011)
    Purification
    Purified by ion-exchange chromatography and gel-filtration from serum-free CHO growth media.
    Protein is sterile-filtrated through 0.22 µg filter.
    Purified human CDNF is characterized as homogenous material by mass-spectroscopy.
    Endotoxin Level
    Less than 1EU/µg of protein as determined by LAL method
    Top Product
    Discover our top product CDNF Protein
  • Comment

    Synonyms: Cerebral dopamine neurotrophic factor - CDNF, ARMETL1

    Restrictions
    For Research Use only
  • Concentration
    1 mg/ml Concentration of the protein is determined by BCA Protein Analysis kit (Pierce). BSA was used as a standard
    Buffer
    PBS pH 7.5
    Handling Advice
    Recommended to aliquot into smaller quantities. Avoid repeated freeze-thaw cycles.
    Storage
    -80 °C
  • Target
    CDNF (Cerebral Dopamine Neurotrophic Factor (CDNF))
    Alternative Name
    CDNF (CDNF Products)
    Synonyms
    ARMETL1 Protein, 9330140G23 Protein, Armetl1 Protein, cerebral dopamine neurotrophic factor Protein, CDNF Protein, Cdnf Protein
    Background
    CDNF is a trophic factor for midbrain dopamine neurons in vivo. It prevents the 6-OHDA- (Lindholm et al. 20007, Voutilainen et al., 2011) and MPTP-induced degeneration (Airavaara et al., 2012) of dopamine neurons in rodent models of Parkinson’s disease. When administered after 6-OHDA or MPTP –lesioning it restores the dopaminergic function and prevents degeneration of dopamine neurons in substantia nigra pars compacta.
    Molecular Weight
    Approximately 18.5 kDa, a single non-glycosylated polypeptide chain containing 163 amino acids.
    UniProt
    Q49AH0
You are here:
Support